Boundless Bio, Inc. BOLD
2.66
0.06
2.31%
as of 25 Sep
- Market cap
- $59.1M
- P/E
- 0.0×
Follow BOLD
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
9.48 | 9.87 | 8.74 | 10.14 |
+8 more quarters Free account |
Net Debt/EBITDA |
3.14 | 3.37 | 4.51 | 4.78 | |
Debt/Assets |
0.00% | 31.92% | 29.20% | 27.68% | |
Debt/Equity |
0.00 | 0.52 | 0.46 | 0.42 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.89 | 1.10 | 0.78 | 0.73 | |
Capex/Depreciation |
(0.03) | (0.03) | (1.38) | (0.05) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.94) | (0.67) | (0.47) | (0.46) | |
Cash per Share |
3.24 | 4.14 | 4.81 | 5.25 | |
Shareholders Equity per Share |
2.94 | 3.86 | 4.41 | 4.92 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.94 | 3.86 | 4.41 | 4.92 | |
Free Cash Flow |
(21.01) | (14.98) | (10.53) | (10.21) | |
Working Capital |
65.88 | 85.03 | 97.07 | 108.31 | |
Capital Expenditures |
(0.04) | (0.01) | (0.42) | (0.01) | |
Net Current Asset Value |
65.88 | 40.03 | 51.21 | 61.60 | |
| Other line items | |||||
Quick Ratio |
9.35 | 9.69 | 8.58 | 9.93 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.93) | (0.67) | (0.45) | (0.46) | |
Capex per Share |
0.00 | 0.00 | (0.02) | 0.00 | |
Average Payables |
5.43 | 5.33 | 6.04 | 6.91 | |
Average Assets |
126.60 | 166.11 | 181.73 | 171.91 | |
Average Common Equity |
94.33 | 111.49 | 124.65 | 137.63 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates